RKDA - Arcadia Biosciences - Stock Forecast

Basic Materials - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RKDA is currently covered by 1 analysts with an average price target of $7.18. This is a potential upside of $3.3 (85.05%) from yesterday's end of day stock price of $3.88.

Arcadia Biosciences's activity chart (see below) currently has 3 price targets and 15 ratings on display. The stock rating distribution of RKDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 354 days.

Highest price target for RKDA is $6, Lowest price target is $6, average price target is $6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 20-Aug-2024. First documented stock forecast 16-Aug-2020.

Best performing analysts who are covering RKDA - Arcadia Biosciences:

Raghuram Selvaraju

Currently out of the existing stock ratings of RKDA, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$2.12 (54.64%)

$6

8 months 20 days ago
(20-Aug-2024)

3/8 (37.5%)

$3.3 (122.22%)

354

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RKDA (Arcadia Biosciences) average time for price targets to be met?

On average it took 354 days on average for the stock forecasts to be realized with a an average price target met ratio 37.5

Which analyst has the current highest performing score on RKDA (Arcadia Biosciences) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on RKDA (Arcadia Biosciences)?

Raghuram Selvaraju has 3 price targets and 16 ratings on RKDA

Which analyst is the currently most bullish on RKDA (Arcadia Biosciences)?

Raghuram Selvaraju with highest potential upside - $2.12

Arcadia Biosciences in the News

Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

— Revenues increase 22% year over year driven by 90% growth in Zola® — — Arcadia sells patents for $750K and eliminates $1M in liabilities — — Roosevelt agreement amended to provide greater certainty regarding exchange ratio — DALLAS, May 08, 2025 (GLOBE NEWSWIRE) — Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?